⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

BioXcel Therapeutics, Inc. Common Stock

$1.04
-0.01 (-0.62%)

Volume:

1.481K ($1.54K)

Market Capitalization:

$32.11M

BioXcel Therapeutics Price Chart

BioXcel Therapeutics Price Chart1:29 PM2:49 PM4:09 PM5:29 PM6:49 PM4:09 AM5:29 AM1.091.081.071.061.061.051.04

BioXcel Therapeutics Volume Chart

BioXcel Therapeutics Volume Chart1:29 PM2:49 PM4:09 PM5:29 PM6:49 PM4:09 AM5:29 AM83.42K71.51K59.59K47.67K35.75K23.84K11.92K

BioXcel Therapeutics Market Segments

Premarket

-0.04(-3.70%)
Open$1.08
Close$1.04
Low$1.04
Low Change-0.04 (-3.70%)
High$1.09
High Change+0.01 (+0.63%)
Range$0.05
Volume1.481K
Dollar Volume$1.54K

Overnight

+0.00(+0.00%)
Open$1.07
Close$1.07
Low$1.07
Low Change0.00 (0.00%)
High$1.07
High Change+0.00 (+0.00%)
Range$0.00
Volume135
Dollar Volume$144.45

After Hours Yesterday

+0.02(+1.92%)
Open$1.04
Close$1.06
Low$1.04
Low Change0.00 (0.00%)
High$1.08
High Change+0.04 (+3.85%)
Range$0.04
Volume43.633K
Dollar Volume$46.25K

Regular Trading Hours Yesterday

-0.06(-5.72%)
Open$1.11
Close$1.05
Low$1.04
Low Change-0.07 (-6.31%)
High$1.12
High Change+0.01 (+0.90%)
Range$0.08
Volume3.937M
Dollar Volume$4.12M

Premarket Yesterday

+0.01(+0.90%)
Open$1.11
Close$1.12
Low$1.09
Low Change-0.02 (-1.50%)
High$1.16
High Change+0.05 (+4.50%)
Range$0.07
Volume38.545K
Dollar Volume$43.17K

BioXcel Therapeutics News

There is no current news for this stock at the moment.

BioXcel Therapeutics Top Trades

BioXcel Therapeutics's top trade so far today returned +0.63%, while the top short trade returned -4.31%.

BioXcel Therapeutics Moving Averages

5 Day Moving Average (SMA5)$1.26
10 Day Moving Average (SMA10)$1.29
20 Day Moving Average (SMA20)$1.22
50 Day Moving Average (SMA50)$1.20
100 Day Moving Average (SMA100)$1.30
200 Day Moving Average (SMA200)$1.68

BioXcel Therapeutics Statistics

Average Volume (30 Days)780.84K
P/E Ratio (Current)-.45
EPS (Current)-$2.44
Dividend Yield0.00%
Free Cash Flow
Cash Ratio0.31
Current Ratio0.62
Quick Ratio0.61
Debt to Equity-0.95
Enterprise Value$117.07M
EV to EBITDA-2.34
EV to Sales172.17
Price to Book-0.32
Price to Cash Flow
Price to Free Cash Flow
Price to Sales49.95
Return on Assets-2.21%
Return on Equity0.71%

BioXcel Therapeutics Stock Splits

There has been 1 stock split for BioXcel Therapeutics (BTAI). The reverse stock split occured on February 10, 2025 and reduced the outstanding shares at a ratio of 16:1.

DateTypeRatio
Feb 10, 2025Reverse16:1

BioXcel Therapeutics Dividends

There have been no dividends for BioXcel Therapeutics (BTAI).